| Characteristics and outcomes of in-hospital cardiac arrest events during the COVID-19 pandemic: a single-center experience from a new york city public hospital JA Miles, M Mejia, S Rios, SI Sokol, M Langston, S Hahn, E Leiderman, ... Circulation: Cardiovascular Quality and Outcomes 13 (11), e007303, 2020 | 53 | 2020 |
| Multiple myeloma in Hispanics: incidence, characteristics, survival, results of discovery, and validation using real-world and connect MM registry data G Kaur, MM Saldarriaga, N Shah, DD Catamero, L Yue, N Ashai, ... Clinical Lymphoma Myeloma and Leukemia 21 (4), e384-e397, 2021 | 27 | 2021 |
| Collection of biospecimens from the inspiration4 mission establishes the standards for the space omics and medical atlas (SOMA) EG Overbey, K Ryon, JK Kim, BT Tierney, R Klotz, V Ortiz, S Mullane, ... Nature Communications 15 (1), 4964, 2024 | 17 | 2024 |
| Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance M Mejia Saldarriaga, W Darwiche, D Jayabalan, J Monge, C Rosenbaum, ... Frontiers in Oncology 12, 1020011, 2022 | 7 | 2022 |
| A Case of CCDC6-RET Fusion Mutation in Adult Acute Lymphoblastic Leukemia (ALL), a Known Activating Mutation Reported in ALL M Mejia Saldarriaga, A Steinberg, EA Severson, A Binder Frontiers in Oncology 9, 1303, 2019 | 5 | 2019 |
| Association of hydroxychloroquine use and Hemolytic Anemia in patients with low levels of Glucose-6-Phosphate Dehydrogenase IER de Oleo, MM Saldarriaga, BK Johnson JCR: Journal of Clinical Rheumatology 28 (1), e23-e25, 2022 | 4 | 2022 |
| Teclistamab demonstrates clinical activity in real-world patients ineligible for the pivotal Majestec-1 trial B Gordon, L Fogel, G Varma, MM Saldarriaga, J Ahn, A Aleman, J Caro, ... Blood 142, 4741, 2023 | 3 | 2023 |
| Retrospective study: association of hydroxychloroquine use and hemolytic anemia in patients with low levels of glucose-6-phosphate dehydrogenase (G6PD) MM Saldarriaga, IER de Oleo, B Johnson ARTHRITIS & RHEUMATOLOGY 70, 2018 | 3 | 2018 |
| How artificial intelligence revolutionizes the world of multiple myeloma M Romero, A Mosquera Orgueira, M Mejía Saldarriaga Frontiers in Hematology 3, 1331109, 2024 | 2 | 2024 |
| Angioimmunoblastic T-cell lymphoma presenting with severe plasmacytosis mimicking plasma cell leukemia MM Saldarriaga, M Alhomoud, G Roboz, JN Allan, J Ruan, MM Ouseph, ... American Journal of Hematology, 2023 | 2 | 2023 |
| Multiple myeloma in Hispanics is associated with better survival than non-Hispanic African Americans and Whites: Analysis from a large single center minority rich cohort G Kaur, MM Saldarriaga, A Acuna-Villaorduna, M Kazemi, S Jasra, ... Blood 132, 3601, 2018 | 2 | 2018 |
| Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma M Mejia Saldarriaga, D Pan, C Unkenholz, TH Mouhieddine, ... Blood Advances 8 (15), 3859-3869, 2024 | 1 | 2024 |
| A novel digital educational strategy improves treatment adherence and quality of life in patients with multiple myeloma J Guio, A Melo, MM Saldarriaga, C Fuentes, N Tíjaro-Ovalle, A Borda, ... Journal of Cancer Education 39 (1), 50-57, 2024 | 1 | 2024 |
| Genomic and Transcriptional Characterization of Primary Mediastinal Large B Cell Lymphoma RJ Leeman-Neill, D Thakkar, SL Ondrejka, ED Hsi, A Chadburn, ... Blood 138, 2398, 2021 | 1 | 2021 |
| Real world treatment patterns and toxicity among elderly patients with multiple myeloma JD Gonzalez-Lugo, A Acuna-Villaorduna, J Heisler, N Goradia, D Cole, ... Blood 134, 5571, 2019 | 1 | 2019 |
| Polyglandular Autoimmune Syndrome Type IIIB: Hyperthyroidism and Pernicious Anemia, a Reminder of the Past IER De Oleo, MM Saldarriaga, M Silverman, S Thibaud, LR Sponholz Journal of Endocrinology and Metabolism 7 (5), 159-161, 2017 | 1 | 2017 |
| Effect of daratumumab on light chain reduction in newly diagnosed multiple myeloma with light chain cast nephropathy. JE Velez-Hernandez, M Mejia Saldarriaga, M Bustoros, RN Pearse, ... Journal of Clinical Oncology 42 (16_suppl), 7554-7554, 2024 | | 2024 |
| Post CAR-T lymphocytosis as a surrogate of BCMA CAR-T expansion, response, and prognosis in multiple myeloma MM Saldarriaga, D Pan, C Unkenholz, T Mouhieddine, J Fein, J Monge, ... Cancer Research 84 (6_Supplement), 3619-3619, 2024 | | 2024 |
| Post CAR-T Peripheral Lymphocytosis and Its Kinetics Are a Potential Biomarker for Response and Immune Mediated Toxicities MM Saldarriaga, C Unkenholz, JA Fein, J Monge, C Rosenbaum, ... Blood 142, 3341, 2023 | | 2023 |
| P-358 Myeloma at a younger age presents with distinctive clinical and molecular features MM Saldarriaga, A Sowa, J Contreras, D Jayabalan, C Rosenbaum, ... Clinical Lymphoma Myeloma and Leukemia 23, S236-S237, 2023 | | 2023 |
